1. Home
  2. THRD vs TG Comparison

THRD vs TG Comparison

Compare THRD & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • TG
  • Stock Information
  • Founded
  • THRD 2019
  • TG 1988
  • Country
  • THRD United States
  • TG United States
  • Employees
  • THRD N/A
  • TG N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • TG Metal Fabrications
  • Sector
  • THRD Health Care
  • TG Industrials
  • Exchange
  • THRD Nasdaq
  • TG Nasdaq
  • Market Cap
  • THRD 335.2M
  • TG 271.9M
  • IPO Year
  • THRD 2022
  • TG 1989
  • Fundamental
  • Price
  • THRD $3.47
  • TG $8.12
  • Analyst Decision
  • THRD Buy
  • TG
  • Analyst Count
  • THRD 3
  • TG 0
  • Target Price
  • THRD $14.00
  • TG N/A
  • AVG Volume (30 Days)
  • THRD 1.2M
  • TG 75.6K
  • Earning Date
  • THRD 03-25-2025
  • TG 03-14-2025
  • Dividend Yield
  • THRD N/A
  • TG N/A
  • EPS Growth
  • THRD N/A
  • TG N/A
  • EPS
  • THRD N/A
  • TG N/A
  • Revenue
  • THRD N/A
  • TG $717,366,000.00
  • Revenue This Year
  • THRD N/A
  • TG N/A
  • Revenue Next Year
  • THRD N/A
  • TG N/A
  • P/E Ratio
  • THRD N/A
  • TG N/A
  • Revenue Growth
  • THRD N/A
  • TG N/A
  • 52 Week Low
  • THRD $3.18
  • TG $3.98
  • 52 Week High
  • THRD $16.94
  • TG $9.22
  • Technical
  • Relative Strength Index (RSI)
  • THRD 25.71
  • TG 57.93
  • Support Level
  • THRD $3.18
  • TG $7.83
  • Resistance Level
  • THRD $3.70
  • TG $8.34
  • Average True Range (ATR)
  • THRD 0.31
  • TG 0.24
  • MACD
  • THRD 0.10
  • TG 0.01
  • Stochastic Oscillator
  • THRD 13.26
  • TG 66.91

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About TG Tredegar Corporation

Tredegar Corp through its subsidiaries engaged in the manufacture of Polyethylene Plastic films, Polyester Films, and Aluminum Extrusions. Polyethylene Plastic films manufacture plastic films, elastics and laminate materials which are utilized in personal care materials, surface protection films, and specialty and optical lighting applications. It operates through PE Films, Flexible Packaging Films, and Aluminum Extrusions segments. Aluminum Extrusions generates the majority of revenue and produces high-quality, soft-alloy, and medium-strength aluminum use for building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. It generates revenue from the United States, Asia, and Brazil.

Share on Social Networks: